 Vinblastine response renal cancer high response rate patients pulmonary metastases sixty-five patients interferon Wellferon Burroughs Wellcome Co Research Triangle Park NC vinblastine initial six-cycle induction treatment interferon daily doses weeks Vinblastine dose day alternate cycles Toxicities overall response rate significant difference treatment arms Survival different arms small subset patients metastases lungs high complete response CR partial response PR rate Responses durable overall survival group patients